549 related articles for article (PubMed ID: 25037082)
1. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
[TBL] [Abstract][Full Text] [Related]
2. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Semin Neurol; 2012 Jul; 32(3):237-45. PubMed ID: 23117948
[TBL] [Abstract][Full Text] [Related]
3. Inclusion body myositis.
Dimachkie MM; Barohn RJ
Curr Neurol Neurosci Rep; 2013 Jan; 13(1):321. PubMed ID: 23250766
[TBL] [Abstract][Full Text] [Related]
4. [Inclusion body myositis (IBM) -- a review].
Czaplinski A; Renaud S; Fuhr P
Praxis (Bern 1994); 2003 Apr; 92(14):649-54. PubMed ID: 12723314
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic inflammatory myopathies.
Dimachkie MM
J Neuroimmunol; 2011 Feb; 231(1-2):32-42. PubMed ID: 21093064
[TBL] [Abstract][Full Text] [Related]
6. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
7. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ; Amato AA
Neurol Clin; 2014 Aug; 32(3):595-628, vii. PubMed ID: 25037081
[TBL] [Abstract][Full Text] [Related]
9. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ
Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
[TBL] [Abstract][Full Text] [Related]
11. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
van de Vlekkert J; Hoogendijk JE; de Visser M
Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
[TBL] [Abstract][Full Text] [Related]
12. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
Dalakas MC
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic inflammatory myopathies.
Amato AA; Barohn RJ
Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
[TBL] [Abstract][Full Text] [Related]
14. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
15. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
Dalakas MC
Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
[TBL] [Abstract][Full Text] [Related]
17. Genetic Influences in Cancer-Associated Myositis.
Patasova K; Lundberg IE; Holmqvist M
Arthritis Rheumatol; 2023 Feb; 75(2):153-163. PubMed ID: 36053262
[TBL] [Abstract][Full Text] [Related]
18. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]